TA Associates to acquire German care leader Alloheim
Global private equity firm TA Associates has reached an agreement to become the new anchor shareholder in Alloheim Senioren-Residenzen, marking a significant transition for Germany’s largest private provider of inpatient and outpatient care services. The transaction involves the full exit of Nordic Capital, which has supported the development and expansion of the Düsseldorf-based group since 2018. While specific financial terms…
Ramsay Santé prepares for independence ahead of December demerger
Australia’s Ramsay Health Care is giving away its 52.79% stake in French hospital giant Ramsay Santé to its own shareholders, who will get 0.25 Ramsay Santé shares for every Ramsay share they own. This landmark demerger, which remains subject to shareholder approval at a general meeting on November 24, represents a fundamental shift in the group’s global strategy. The parent…
Ferring Pharmaceuticals acquiring Gameto for up to $1.38bn
Swiss pharmaceutical group Ferring Pharmaceuticals has entered into a definitive agreement to acquire New York-based biotechnology company Gameto in a transaction valued at up to $1.38bn. The acquisition represents a major strategic expansion for Ferring in its core therapeutic area of reproductive medicine and maternal health. The transaction features a structured payment system that includes an upfront payment alongside substantial…
ARCHIMED takes majority stake in medical imaging cloud company
Global healthcare private equity specialist ARCHIMED has announced that its Healthcare IT team has acquired a majority stake in 3verest, a London-headquartered provider of sovereign cloud infrastructure dedicated to medical imaging. For healthcare operators and investors, the transaction highlights the rising critical importance of data sovereignty in clinical environments. Unlike traditional cloud providers that often resell capacity from global hyperscalers,…
Healthcare Activos acquires in Germany and Portugal
Leading European long-term investment platform and REIT Healthcare Activos has significantly expanded its footprint in the German market through the acquisition specialised mental health clinics from Median Group. The acquisition of two substantial clinics represents a strategic entry for the real estate platform into Germany’s psychosomatic care and mental health segment. This deal follows the initial entry of Healthcare Activos…
EQT acquires molecular diagnostics specialist in €10.80bn takeover
Swedish private equity group EQT is acquiring listed German-Dutch diagnostics specialist Qiagen in a transaction that values the target at an enterprise value of approximately €10.80bn. The transaction represents a major consolidation in the European life sciences and molecular diagnostics landscape. Qiagen operates extensively across sample preparation, molecular diagnostics, and life sciences research fields, with its technologies widely deployed in…
Merck to acquire London biotech company for $1.1bn
German multinational science and technology company Merck KGaA has announced a definitive agreement to acquire London-headquartered biotech company Silence Therapeutics. This transaction represents a significant expansion of the Darmstadt based group’s rare disease and specialty healthcare portfolio, reinforcing its ambition to become a global leader in specialised innovation. The deal carries an enterprise value of roughly $1.1bn. The transaction’s primary…
Healthspan to acquire Ireland-based Centric Health
US-based healthcare organisation Healthspan Partners has reached an agreement to acquire Centric Health, the leading primary healthcare provider in Ireland. The transaction, which involves a fast-growing network of primary care clinics, marks a significant shift in ownership for the Dublin-based business which has been under the control of Five Arrows, the alternative assets division of Rothschild and Company, since 2018.…
Siemens Healthineers exits general ultrasound market
Siemens Healthineers is to completely exit the highly competitive general-purpose ultrasound market. The strategic shift is part of a broader corporate realignment designed to optimise the Germany-based imaging giant’s product portfolio, protect operating margins, and concentrate resources on high-growth, high-value clinical applications. General-purpose ultrasound systems have faced severe pricing pressure and market stagnation in recent years, particularly in China and…
AstraZeneca agrees $1.5bn AI Deal and $2bn partnership
Biopharmaceutical giant AstraZeneca has struck two significant deals: a strategic drug discovery collaboration and licensing agreement with US-based artificial intelligence therapeutics specialist Insitro, and a two billion dollar strategic transaction with US, UK and Ireland-based oncology specialist Summit Therapeutics. Under the terms of the Insitro agreement, AstraZeneca will pay Insitro an upfront payment of $40m. Insitro is also eligible to…